Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1159/000494838 | ||||
| Año | 2020 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Objective: There is a need for standardized reference values for cardiac dimensions in prenatal life. The objective of the present study was to construct nomograms for fetal cardiac dimensions using a well-defined echocardiographic methodology in a low-risk population. Methods: This is a prospective cohort study including 602 low-risk singleton pregnancies undergoing a standardized fetal echocardiography to accurately assess fetal cardiac, ventricular, and atrial dimensions. Parametric regressions were tested to model each measurement against gestational age from 18 to 41 weeks of gestation. Results: Nomograms were constructed for fetal cardiac dimensions (transverse and longitudinal diameters and areas) of the whole heart, atria, and ventricles, as well as myocardial wall thicknesses. All dimensions showed a progressive increase with gestational age. The best model for most parameters was a second-degree linear polynomial. Fetal cardiac, ventricular, and atrial diameters and areas were successfully obtained in 98.6% of the fetuses, while myocardial wall thicknesses could be obtained in 96.5% of the population. The results showed excellent interobserver and intraobserver reproducibility (intraclass correlation coefficient, ICC > 0.811 and ICC > 0.957, respectively). Conclusions: We provide standardized and comprehensively evaluated reference values for fetal cardiac morphometric parameters across gestation in a low-risk population. These no mograms would enable the early identification of different patterns of fetal cardiac remodeling.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Garcia-Otero, Laura | Mujer |
Universitat de Barcelona - España
Univ Barcelona - España Ctr Biomed Res Rare Dis CIBER ER - España |
| 2 | Gomez, Olga | Mujer |
Universitat de Barcelona - España
Univ Barcelona - España Ctr Biomed Res Rare Dis CIBER ER - España |
| 3 | Rodríguez-López, Mérida | - |
Universitat de Barcelona - España
Pontificia Universidad Javeriana, Cali - Colombia Univ Barcelona - España Ctr Biomed Res Rare Dis CIBER ER - España Pontificia Univ Javeriana Secc Cali - Colombia |
| 4 | Torres, Ximena | Mujer |
Universitat de Barcelona - España
Univ Barcelona - España Ctr Biomed Res Rare Dis CIBER ER - España |
| 5 | Soveral, Iris | Mujer |
Universitat de Barcelona - España
Univ Barcelona - España Ctr Biomed Res Rare Dis CIBER ER - España |
| 6 | RUIZ-MARTINEZ, A. | Hombre |
Universitat de Barcelona - España
Hospital Clínico de la Universidad de Chile - Chile Univ Barcelona - España Ctr Biomed Res Rare Dis CIBER ER - España Hosp Clin Univ Chile - Chile Hospital Clínico Universidad de Chile - Chile |
| 7 | Guirado, Laura | Mujer |
Universitat de Barcelona - España
Univ Barcelona - España Ctr Biomed Res Rare Dis CIBER ER - España |
| 8 | Valenzuela-Alcaraz, B. | Mujer |
Universitat de Barcelona - España
Univ Barcelona - España Ctr Biomed Res Rare Dis CIBER ER - España |
| 9 | López, Marta | Mujer |
Universitat de Barcelona - España
Univ Barcelona - España Ctr Biomed Res Rare Dis CIBER ER - España |
| 10 | Martínez, Josep Maria | Hombre |
Universitat de Barcelona - España
Ctr Biomed Res Rare Dis CIBER ER - España |
| 10 | Maria Martinez, Josep | Hombre |
Univ Barcelona - España
Ctr Biomed Res Rare Dis CIBER ER - España Universitat de Barcelona - España |
| 11 | Gratacos, Eduardo | Hombre |
Universitat de Barcelona - España
Univ Barcelona - España Ctr Biomed Res Rare Dis CIBER ER - España |
| 12 | Crispi, F. | Mujer |
Universitat de Barcelona - España
Univ Barcelona - España Ctr Biomed Res Rare Dis CIBER ER - España |
| Fuente |
|---|
| Instituto de Salud Carlos III |
| "la Caixa" Foundation |
| Erasmus+ Programme of the European Union |
| FI AGAUR |
| Ajut Josep Font (Hospital Clinic de Barcelona, Spain) |
| FI AGAUR |
| Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK) AGAUR 2017 SGR grant |
| Agradecimiento |
|---|
| This project has been funded with support of the Erasmus+ Programme of the European Union (Framework Agreement No. 2013-0040). This publication reflects the views of the authors only, and the Commission cannot be held responsible for any use that may be made of the information contained therein. Additionally, the research leading to these results has received funding from "la Caixa" Foundation (LCF/PR/GN14/10270005), Instituto de Salud Carlos III (PI14/00226, INT16/00168, PI17/00675, PI15/00263, PI15/00130) integrados en el Plan Nacional de I+D+I y cofinanciados por el ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER) "Una manera de hacer Europa," Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK) AGAUR 2017 SGR grant No. 1531, and Ajut Josep Font (Hospital Clinic de Barcelona, Spain). L.G.-O. received a grant from FI AGAUR (2016FI_B01184). |